CLEARPOINT NEURO INC (CLPT) — insider trading
Health Care · NASDAQ
CLEARPOINT NEURO INC (CLPT) has 42 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 42 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Richards Timothy T. | Director | Grant / award / vesting | 319 | $12.21 | $3.9K | Form 4 |
| 2026-10-01 | FLETCHER R JOHN | Director | Grant / award / vesting | 993 | $12.21 | $12.1K | Form 4 |
| 2026-09-02 | BURNETT JOSEPH | Director, Officer (CEO and President) | Option exercise / conversion (derivative) | 12,517 | — | $0 | Form 4 |
| 2026-09-02 | BURNETT JOSEPH | Director, Officer (CEO and President) | Option exercise / conversion | 12,517 | $3.47 | $43.4K | Form 4 |
| 2026-07-01 | Richards Timothy T. | Director | Grant / award / vesting | 222 | $17.84 | $4.0K | Form 4 |
| 2026-07-01 | FLETCHER R JOHN | Director | Grant / award / vesting | 662 | $17.84 | $11.8K | Form 4 |
| 2026-06-30 | BURNETT JOSEPH | Director, Officer (CEO and President) | Grant / award / vesting | 1,361 | $11.93 | $16.2K | Form 4 |
| 2026-06-30 | D'Alessandro Danilo | Officer (Chief Financial Officer) | Grant / award / vesting | 1,085 | $11.93 | $12.9K | Form 4 |
| 2026-06-30 | STIGALL L. JEREMY | Officer (Chief Business Officer) | Grant / award / vesting | 1,781 | $11.93 | $21.2K | Form 4 |
| 2026-06-29 | BURNETT JOSEPH | Director, Officer (CEO and President) | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-29 | BURNETT JOSEPH | Director, Officer (CEO and President) | Open-market sale | 20,000 | $19.38 | $387.6K | Form 4 |
| 2026-06-29 | BURNETT JOSEPH | Director, Officer (CEO and President) | Option exercise / conversion | 20,000 | $2.50 | $50.0K | Form 4 |
| 2026-06-17 | BURNETT JOSEPH | Director, Officer (CEO and President) | Option exercise / conversion (derivative) | 60,000 | — | $0 | Form 4 |
| 2026-06-17 | BURNETT JOSEPH | Director, Officer (CEO and President) | Open-market sale | 1,843 | $17.94 | $33.1K | Form 4 |
| 2026-06-17 | BURNETT JOSEPH | Director, Officer (CEO and President) | Open-market sale | 60,000 | $17.79 | $1.07M | Form 4 |
| 2026-06-17 | BURNETT JOSEPH | Director, Officer (CEO and President) | Option exercise / conversion | 60,000 | $2.50 | $150.0K | Form 4 |
| 2026-06-04 | Richards Timothy T. | Director | Option exercise / conversion (derivative) | 500 | $10.00 | $5.0K | Form 4 |
| 2026-06-04 | Richards Timothy T. | Director | Shares withheld for taxes / exercise cost | 376 | $13.30 | $5.0K | Form 4 |
| 2026-06-04 | Richards Timothy T. | Director | Option exercise / conversion | 500 | $10.00 | $5.0K | Form 4 |
| 2026-06-01 | Richards Timothy T. | Director | Open-market sale | 5,415 | $12.17 | $65.9K | Form 4 |
| 2026-05-21 | JOHNSON B KRISTINE | Director | Grant / award / vesting (derivative) | 12,820 | — | $0 | Form 4 |
| 2026-05-21 | FLETCHER R JOHN | Director | Grant / award / vesting (derivative) | 12,820 | — | $0 | Form 4 |
| 2026-05-21 | Richards Timothy T. | Director | Grant / award / vesting (derivative) | 12,820 | — | $0 | Form 4 |
| 2026-05-21 | Klein Matthew B. | Director | Grant / award / vesting (derivative) | 12,820 | — | $0 | Form 4 |
| 2026-05-21 | Klein Matthew B. | Director | Open-market sale | 16,000 | $11.59 | $185.4K | Form 4 |
| 2026-05-21 | LIAU LINDA M. | Director | Grant / award / vesting (derivative) | 12,820 | — | $0 | Form 4 |
| 2026-05-21 | FALLON LYNNETTE C | Director | Grant / award / vesting (derivative) | 12,820 | — | $0 | Form 4 |
| 2026-05-20 | FALLON LYNNETTE C | Director | Open-market sale | 5,091 | $11.14 | $56.7K | Form 4 |
| 2026-05-19 | LIAU LINDA M. | Director | Option exercise / conversion (derivative) | 12,417 | — | — | Form 4 |
| 2026-05-19 | LIAU LINDA M. | Director | Option exercise / conversion | 12,417 | — | — | Form 4 |
| 2026-05-19 | Girin Pascal E R | Director | Option exercise / conversion (derivative) | 12,417 | — | — | Form 4 |
| 2026-05-19 | Girin Pascal E R | Director | Option exercise / conversion | 12,417 | — | — | Form 4 |
| 2026-05-19 | JOHNSON B KRISTINE | Director | Option exercise / conversion (derivative) | 12,417 | — | — | Form 4 |
| 2026-05-19 | JOHNSON B KRISTINE | Director | Option exercise / conversion | 12,417 | — | — | Form 4 |
| 2026-05-19 | Richards Timothy T. | Director | Option exercise / conversion (derivative) | 12,417 | — | — | Form 4 |
| 2026-05-19 | Richards Timothy T. | Director | Option exercise / conversion | 12,417 | — | — | Form 4 |
| 2026-05-19 | FLETCHER R JOHN | Director | Option exercise / conversion (derivative) | 12,417 | — | — | Form 4 |
| 2026-05-19 | FLETCHER R JOHN | Director | Option exercise / conversion | 12,417 | — | — | Form 4 |
| 2026-05-19 | FALLON LYNNETTE C | Director | Option exercise / conversion (derivative) | 12,417 | — | — | Form 4 |
| 2026-05-19 | FALLON LYNNETTE C | Director | Option exercise / conversion | 12,417 | — | — | Form 4 |
| 2026-05-19 | Klein Matthew B. | Director | Option exercise / conversion (derivative) | 12,417 | — | — | Form 4 |
| 2026-05-19 | Klein Matthew B. | Director | Option exercise / conversion | 12,417 | — | — | Form 4 |
Ask the chat about CLPT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CLEARPOINT NEURO INC (CLPT).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.